SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-16-008375
Filing Date
2016-03-30
Accepted
2016-03-30 08:32:06
Documents
8
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 form20-f.htm 20-F 1737597
2 image_001.jpg GRAPHIC 3060
3 image_002.jpg GRAPHIC 2881
4 image_005.jpg GRAPHIC 29297
5 image_006.jpg GRAPHIC 5974
6 ex12-1.htm EX-12.1 18096
7 ex12-2.htm EX-12.2 17840
8 ex13-1.htm EX-13.1 8588
  Complete submission text file 0001493152-16-008375.txt   1840563
Mailing Address 666 BURRARD STREET SUITE 500 VANCOUVER A1 V6C 2X8
Business Address 666 BURRARD STREET SUITE 500 VANCOUVER A1 V6C 2X8 778-379-0040
SciVac Therapeutics Inc. (Filer) CIK: 0000764195 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0331
Type: 20-F | Act: 34 | File No.: 000-13248 | Film No.: 161537108
SIC: 1040 Gold and Silver Ores